Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR

Analysis of circulating cell-free tumor DNA (cftDNA) has emerged as a specific and sensitive blood-based approach to detect epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) patients. Still, there is some debate on what should be the preferential clinical method...

Descripción completa

Detalles Bibliográficos
Autores principales: Siggillino, Annamaria, Ulivi, Paola, Pasini, Luigi, Reda, Maria Sole, Chiadini, Elisa, Tofanetti, Francesca Romana, Baglivo, Sara, Metro, Giulio, Crinó, Lucio, Delmonte, Angelo, Minotti, Vincenzo, Roila, Fausto, Ludovini, Vienna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762356/
https://www.ncbi.nlm.nih.gov/pubmed/33297595
http://dx.doi.org/10.3390/diagnostics10121062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762356/
https://www.ncbi.nlm.nih.gov/pubmed/33297595
http://dx.doi.org/10.3390/diagnostics10121062

Ejemplares similares